Skip to main navigation Skip to search Skip to main content

Comparison of Zaire ebolavirus realtime RT-PCRs targeting the nucleoprotein gene

  • Anne J. Jääskeläinen*
  • , Tarja Sironen
  • , Minttu Kaloinen
  • , Laura Kakkola
  • , Ilkka Julkunen
  • , Roger Hewson
  • , Manfred W. Weidmann
  • , Ali Mirazimi
  • , Robert Watson
  • , Olli Vapalahti
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

In last five years, the Africa has faced two outbreaks of Zaire ebolavirus. These outbreaks have been the largest so far, and latest outbreak is still ongoing and affecting the Democratic Republic of the Congo. We tested in parallel three different Zaire ebolavirus (EBOV) realtime RT-PCRs targeting the nucleoprotein gene (EBOV NP-RT-qPCRs) described by Trombley et al. (2010); Huang et al. (2012) and Weidmann et al. (2004). These assays are used regularly in diagnostic laboratories. The limit of detection (LOD), intra-assay repeatability using different matrixes, sensitivity and specificity were determined. In addition, the primers and probes were aligned with the sequences available in ongoing and past outbreaks in order to check the mismatches. The specificity of all three EBOV NP-RT-qPCRs were excellent (100 %), and LODs were under or 10 copies per PCR reaction. Intra-assay repeatability was good in all assays, however the Ct-values were bit higher using the EDTA-blood based matrix. All of the primers and probes in EBOV NP-RT-qPCR assays have one or more mismatches in the probes and primers when the 2267 Zaire EBOV NP sequences, including strains Ituri from DRC outbreak (year 2018), was aligned. The EBOV strain of Bikoro (year 2018) circulating in DRC was 100 % match in Trombley and Weidmann assay, but had one mismatch in Huang assay.

Original languageEnglish
Article number113941
JournalJournal of Virological Methods
Volume284
DOIs
Publication statusPublished - Oct 2020

Bibliographical note

Funding Information:
This project is part of the EbolaMoDRAD (Ebola virus: modern approaches for developing bedside rapid diagnostics) consortium, which has received funding from the Innovative Medicine Initiative 2 Joint Undertaking under grant agreement N?115843. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA. Additional funding was received from Helsinki University Hospital Funds (project TYH2019263).

Funding Information:
This project is part of the EbolaMoDRAD (Ebola virus: modern approaches for developing bedside rapid diagnostics) consortium, which has received funding from the Innovative Medicine Initiative 2 Joint Undertaking under grant agreement N°115843 . This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA . Additional funding was received from Helsinki University Hospital Funds (project TYH2019263).

Publisher Copyright:
© 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Ebola
  • Nucleoprotein
  • PCR
  • Zaire

Fingerprint

Dive into the research topics of 'Comparison of Zaire ebolavirus realtime RT-PCRs targeting the nucleoprotein gene'. Together they form a unique fingerprint.

Cite this